|
|
 |
|
Viewing report
|
|
|
|
Japan: Pharmaceuticals Industry Guide
Datamonitor, March 2011, Pages: 77
The Japan: Pharmaceuticals Industry Guide is an essential resource for top-level data and analysis covering the Japan Pharmaceuticals industry. It includes detailed data on market size and segmentation, textual analysis of the key trends and competitive landscape. This incisive report provides expert analysis with distinct chapters for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Scope of the Report
- Contains an executive summary and data on value, volume and segmentation for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
- Provides textual analysis of the industry's prospects
- Incorporates in-depth five forces competitive environment analysis and scorecards
- Includes five-year forecasts for Biotechnology, Generics, OTC Pharmaceuticals and Pharmaceuticals
Highlights
The Japanese biotechnology market had total revenue of $33.7 billion in 2009, representing a compound annual growth rate (CAGR) of 13% for the period spanning 2005-2009.
The Japanese generics market had total revenue of $3.3 billion in 2009, representing a compound annual growth rate (CAGR) of 6.1% for the period spanning 2005-2009.
The Japanese OTC pharmaceuticals market generated total revenues of $12 billion in 2009, representing a compound annual growth rate (CAGR) of 1.9% for the period spanning 2005-2009.
The Japanese pharmaceuticals market had total revenue of $72.4 billion in 2009, representing a compound annual growth rate (CAGR) of 4.4% for the period spanning 2005-2009.
Why you should buy this report
- Spot future trends and developments
- Inform your business decisions
- Add weight to presentations and marketing materials
- Save time carrying out entry-level research
|
|
|
|
